Table 7.

Potential predictors for the incidence of MACCEs in patients with NSTE-ACS who underwent PCI.

Variables	Univariate			Multivariate
	HR	95% CI	P	HR	95% CI	P
Female	1.305	0.601–2.834	0.501
Age (years)	0.976	0.943–1.010	0.163
Hypertension (%)	2.425	1.188–4.950	0.015	6.816	2.986–15.559	<0.001
Diabetes mellitus (%)	1.804	0.876–3.717	0.110
Current smoking (%)	1.022	0.504–2.073	0.952
Current drinking (%)	0.972	0.419–2.257	0.948
Family history of CAD (%)	0.783	0.238–2.576	0.688
History of myocardial infarction	1.678	0.587–4.797	0.334
Previous PCI (%)	1.427	0.684–2.979	0.343
Average heart rate (beats/min)	1.035	0.988–1.085	0.147
SDNN	1.003	0.996–1.011	0.412
SDANN	1.006	0.995–1.018	0.276
rMSSD	0.996	0.987–1.005	0.399
Pnn50	1.012	0.991–1.034	0.246
Total power (ms2)	0.997	0.975–1.019	0.795
LF (ms2)	1.048	0.895–1.226	0.562
HF (ms2)	1.088	0.978–1.210	0.122
High LF/HF (>1.08)	0.277	0.124–0.620	0.002	0.335	0.144–0.779	0.011
High DC 24h (>2.42 ms)	0.274	0.123–0.613	0.002	0.306	0.134–0.701	0.005
Number of diseased vessels	1.077	0.701–1.653	0.736
Number of implanted stents	0.989	0.701–1.395	0.949
Pre-PCI QFR	0.660	0.443–0.984	0.041	0.527	0.346–0.802	0.003
High post-PCI of the target vessel (>0.88)	0.156	0.073–0.331	<0.001	0.318	0.129–0.780	0.012
High %QFR increase of the target vessel (>23%)	0.224	0.110–0.458	<0.001	0.161	0.066–0.391	<0.001
Target vascular location	0.748	0.488–1.145	0.181
Minimal lumen diameter of target vessel	1.869	0.751–4.647	0.179
Maximum area stenosis of target vessel	0.982	0.950–1.016	0.295
Lesion length of target vessels	1.002	0.968–1.036	0.924